Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 7
Submit an article Journal homepage
191
Views
20
CrossRef citations to date
0
Altmetric
Original Article

MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5

Qiong ZhangDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; ;Department of Pathology, Bengbu Medical College, Bengbu, ChinaView further author information
,
Huaiyong GanDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; ;Department of Pathology, Bengbu Medical College, Bengbu, ChinaView further author information
,
Wenqing SongDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; ;Department of Pathology, Bengbu Medical College, Bengbu, ChinaView further author information
,
Damin ChaiDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; ;Department of Pathology, Bengbu Medical College, Bengbu, ChinaView further author information
&
Shiwu WuDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; ;Department of Pathology, Bengbu Medical College, Bengbu, ChinaCorrespondence[email protected]
View further author information
Pages 769-776 | Received 09 Mar 2018, Accepted 11 May 2018, Published online: 31 May 2018

References

  • Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–2252.
  • Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
  • Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31:281–286.
  • Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014;371:2499–2509.
  • Qin X, He S, Zhang Y, et al. Diagnosis and staging of superficial esophageal precursor based on pre-endoscopic resection system comparable to endoscopic resection. BMC Cancer. 2014;14:774.
  • Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302–317 e1.
  • Chen GZ, Zhu HC, Dai WS, et al. The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivity. J Thorac Dis. 2017;9:849–859.
  • Di Leva G, Croce CM. MicroRNAs. Clin Biochem. 2013;46:840.
  • Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.
  • van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012;110:496–507.
  • Gu J, Wang Y, Wu X. MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des. 2013;19:1292–1300.
  • Liu R, Liao J, Yang M, et al. The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One. 2012;7:e33987
  • Derouet MF, Liu G, Darling GE. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance. PLoS One. 2014;9:e115589.
  • Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer. 2009;45:2197–2206.
  • Arndt GM, Dossey L, Cullen LM, et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 2009;9:374.
  • Mei LL, Wang WJ, Qiu YT, et al. miR-145-5p suppresses tumor cell migration, invasion and epithelial to mesenchymal transition by regulating the Sp1/NF-kappaB signaling pathway in esophageal squamous cell carcinoma. IJMS. 2017;18:e1833.
  • Cui XB, Li S, Li TT, et al. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma. Oncotarget. 2016;7:1777–1795.
  • Tabrizi M, Khalili M, Vasei M, et al. Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma. Arch Iran Med. 2015;18:173–178.
  • Wu BL, Xu LY, Du ZP, et al. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol. 2011;17:79–88.
  • Wang F, Xia J, Wang N, et al. miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc. Onkologie. 2013;36:754–758.
  • Kano M, Seki N, Kikkawa N, et al. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2010;127:2804–2814.
  • Zhang JH, Du AL, Wang L, et al. Episomal lentiviral vector-mediated miR-145 overexpression inhibits proliferation and induces apoptosis of human esophageal carcinomas cells. PRA. 2016;11:453–460.
  • Liu B, Mao N. Smad5: signaling roles in hematopoiesis and osteogenesis. Int J Biochem Cell Biol. 2004;36:766–770.
  • Zavadil J, Brezinova J, Svoboda P, et al. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60. Leukemia. 1997;11:1187–1192.
  • Hejlik DP, Kottickal LV, Liang H, et al. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor. Cancer Res. 1997;57:3779–3783.
  • Middlebrook BS, Eldin K, Li X, et al. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology. 2009;150:5208–5213.
  • Jiang D, Auguiar RC. MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module. Blood. 2014;123:86–93.
  • Wei F, Yang S, Guo Q, et al. MicroRNA-21 regulates osteogenic differentiation of periodontal ligament stem cells by targeting Smad5. Sci Rep. 2017;7:16608–16615.
  • Xiao WF, Li YS, Lou W, et al. MicroRNA-93-5p may participate in the formation of morphine tolerance in bone cancer pain mouse model by targeting Smad5. Oncotarget. 2016;7:52104–52114.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.